Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cells-Reference-Cited by-同舟云学术

Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cells

Published:2019-01 Issue: Volume:162 Page:334-347
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ramana Murthy Appala Venkata,Narendar Vennu,Kumar Nangunoori Sampath,Aparna Pasula,Durga Bhavani Anagani Kanaka,Gautier Fabien,Barillé-Nion Sophie,Juin Philippe,Mosset Paul,Grée René^ORCID,Levoin Nicolas^ORCID

Funder

“Joint Laboratory for Natural Products and Synthesis towards Affordable Health”

CSIR

CRMPO

“Ligue contre le Cancer, Conseil Interrégional Grand Ouest”

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference45 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. (For selected recent reviews see:)

3. Cell death and the mitochondria: therapeutic targeting of the BCl-2 family-driven pathway;Roy;Br. J. Pharmacol.,2014

4. Small molecule Mcl-1 inhibitors for the treatment of cancer, Pharmacol;Belmar;& Therapeutics,2015

5. Selective inhibitors of Bcl-2 and Bcl-xL: balancing antitumor activity with on-target toxicity;Hennessy;Bioorg. Med. Chem. Lett,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potent dual ligands for dopamine D4 and σ1 receptors;Bioorganic & Medicinal Chemistry;2022-09

2. Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chains;Bioorganic & Medicinal Chemistry Letters;2021-11

3. Tip60‐dependent acetylation of KDM2B promotes osteosarcoma carcinogenesis;Journal of Cellular and Molecular Medicine;2019-06-20